NABI
NABI BIOPHARMACEUTICALSData as of 2012 Q3 (09-30) · 13F snapshot
Summary
NABI BIOPHARMACEUTICALS (NABI) is held by 4 tracked hedge-fund managers, a combined reported value of ~$24.77M; the largest are Dan Loeb, Renaissance Technologies, Izzy Englander. Data as of 2012 Q3, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Quiet
Gurus holding4
Congress trades0
Price—no price
Sectors0
This quarter's moves
Top holderDan LoebNew0
Added0
Trimmed / sold0
Izzy EnglanderHold
Value $68.0K0.0% of portfolio36,3802011 Q4
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Izzy Englander | $68.0K | 0.0% | Hold |
Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.